Core Scientific (CORZW) Debt to Equity (2021 - 2025)
Core Scientific (CORZW) has disclosed Debt to Equity for 5 consecutive years, with -$1.1 as the latest value for Q4 2025.
- Quarterly Debt to Equity rose 3.29% to -$1.1 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.1 through Dec 2025, up 3.29% year-over-year, with the annual reading at -$1.1 for FY2025, 3.29% up from the prior year.
- Debt to Equity hit -$1.1 in Q4 2025 for Core Scientific, down from -$0.85 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $2.06 in Q2 2022 to a low of -$3.47 in Q1 2025.
- Historically, Debt to Equity has averaged -$0.52 across 5 years, with a median of -$0.51 in 2024.
- Biggest five-year swings in Debt to Equity: surged 2168.09% in 2022 and later crashed 388830.33% in 2024.
- Year by year, Debt to Equity stood at $0.49 in 2021, then crashed by 85.11% to $0.07 in 2022, then tumbled by 1682.89% to -$1.15 in 2023, then rose by 0.62% to -$1.14 in 2024, then rose by 3.29% to -$1.1 in 2025.
- Business Quant data shows Debt to Equity for CORZW at -$1.1 in Q4 2025, -$0.85 in Q3 2025, and -$0.89 in Q2 2025.